Obsessive Compulsive Disorder Clinical Trial
Official title:
Internet-based Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Pilot Study
Verified date | September 2010 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main aim of this study is to test whether cognitive behavior therapy could be effective in treating obsessive compulsive disorder. Here, the investigators test the in group effects of a 15 week long treatment delivered via the Internet for residents in Stockholm County.
Status | Completed |
Enrollment | 23 |
Est. completion date | March 2011 |
Est. primary completion date | March 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosed with Obsessive compulsive disorder according to the DSM criteria - Be at least 18 years old - YBOCS >7 Exclusion Criteria: - other primary diagnosis - substance abuse, - psychosis, - bipolar disorder, - suicidal ideation, - adjusted pharmacological treatment the last two months - current psychological treatment for OCD, - been treated with CBT the last two years, - serious somatic disease, - Y---BOCS>31 - hoarding as primary OCD subtype |
Country | Name | City | State |
---|---|---|---|
Sweden | Internetpsykatrienheten, M46, Psykiatri sydväst | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Andersson E, Ljótsson B, Hedman E, Kaldo V, Paxling B, Andersson G, Lindefors N, Rück C. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study. BMC Psychiatry. 2011 Aug 3;11:125. doi: 10.1186/1471-244X-11-125. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. | Yale Brown Obsessive Compulsive Scale (Y-BOCS) | Psychiatrist visit at baseline, after 15 weeks of treatment and 6 months after treatment. | |
Secondary | Change from Baseline of cost data after 15 weeks and 6 months after treatment. | "Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry". In this questionnaire, patients register their monthly health care consumption (e.g. GP visits) as well as time spent in informal health enhancing activities (e.g. self-help groups and informal care from friends). In addition, work loss and work cutback both at work and in the domestic realm is measured. | Self-ratings at baseline, after 15 weeks of treatment and 6 months after treatment. | |
Secondary | Change from Baseline of depressive symptoms after 15 weeks and 6 months after treatment. | The Montgomery Åsberg Depression Rating Scale | Sel-ratings at baseline, after 15 weeks of treatment and 6 months after treatment. | |
Secondary | Change from Baseline of obsessions and compulsions after 15 weeks and 6 months after treatment. | Obsessions and Compulsions Inventory Revised | Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. | |
Secondary | Change from Baseline of quality of life after 15 weeks and 6 months after treatment | EuroQol | Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. | |
Secondary | Change from Baseline of quality of life after 15 weeks and 6 months after treatment | Quality of life inventory | Self-ratings at baseline, after 15 weeks of treatment and at 6 months after treatment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Completed |
NCT02855580 -
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
|
||
Completed |
NCT02202915 -
CBT for Pediatric OCD: Community Training Pilot
|
N/A | |
Completed |
NCT02229903 -
An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD
|
N/A | |
Completed |
NCT01794156 -
Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder
|
N/A | |
Completed |
NCT02089984 -
Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders
|
N/A | |
Recruiting |
NCT00965211 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome
|
N/A | |
Completed |
NCT00723060 -
Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
|
Phase 4 | |
Completed |
NCT01172873 -
D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
|
N/A | |
Not yet recruiting |
NCT00743834 -
Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)
|
Phase 4 | |
Completed |
NCT02421315 -
Overlapping Neural Circuits in Pediatric OCD
|
N/A | |
Completed |
NCT01981317 -
Stepped Care Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT02194075 -
Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder
|
Phase 4 | |
Completed |
NCT01686087 -
Attaining and Maintaining Wellness in Obsessive-compulsive Disorder
|
N/A | |
Terminated |
NCT00997087 -
A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
|
Phase 2 | |
Completed |
NCT01331876 -
Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy
|
N/A | |
Completed |
NCT00533806 -
Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder
|
Phase 3 | |
Completed |
NCT00517244 -
Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
|
N/A | |
Completed |
NCT00169377 -
Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)
|
Phase 1/Phase 2 | |
Completed |
NCT00116532 -
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
|
Phase 4 |